Cargando…

Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China

Objective: To investigate the prevalence of Salmonella Typhi and Paratyphi resistance to quinolones and characterize the underlying mechanism in Jiangsu Province of China. Methods: Antimicrobial susceptibility testing was performed using Kirby-Bauer disc diffusion system. Quinolone resistance-determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Huimin, Cheng, Siyun, Liu, Guoye, Tan, Zhongming, Dong, Chen, Bao, Jinfeng, Hong, Jie, Jin, Dazhi, Bao, Changjun, Gu, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193621/ https://www.ncbi.nlm.nih.gov/pubmed/32355184 http://dx.doi.org/10.1038/s41598-020-64346-0

Ejemplares similares

Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta
por: Nathania, Ignes, et al.
Publicado: (2022)

Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
por: Park, Sunok, et al.
Publicado: (2011)

Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans
por: Casin, Isabelle, et al.
Publicado: (2003)

Novel phytochemical–antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR
por: Jayaraman, Premkumar, et al.
Publicado: (2013)

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection
por: Zhao, Xintong, et al.
Publicado: (2023)

Prevalence of fluoroquinolone resistance and mutations in the gyrA, parC and parE genes of Riemerella anatipestifer isolated from ducks in China
por: Zhu, Dekang, et al.
Publicado: (2019)

Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
por: Tari, Leslie W., et al.
Publicado: (2013)

A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens
por: Park, Steven, et al.
Publicado: (2022)

Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains
por: Hamasuna, Ryoichi, et al.
Publicado: (2018)

gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya
por: Kivata, Mary Wandia, et al.
Publicado: (2019)

Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil
por: Minarini, Luciene A. R., et al.
Publicado: (2012)

Mutations in gyrA & parC genes of Shigella flexneri 2a determining the fluoroquinolone resistance
por: Divya, M.P., et al.
Publicado: (2015)

The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran
por: Nouri, Roghayeh, et al.
Publicado: (2016)

The role of Gene Mutations (gyrA, parC) in Resistance to Ciprofloxacin in Clinical Isolates of Pseudomonas Aeruginosa
por: Arabameri, Nasibeh, et al.
Publicado: (2021)

Association between mutations in gyrA and parC genes of Acinetobacter baumannii clinical isolates and ciprofloxacin resistance
por: Ardebili, Abdollah, et al.
Publicado: (2015)

Detection of gyrA and parC Mutations and Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Klebsiella pneumoniae
por: Kareem, Sawsan Mohammed, et al.
Publicado: (2021)

Resistance Mutations in gyrA and parC are Common in Escherichia Communities of both Fluoroquinolone-Polluted and Uncontaminated Aquatic Environments
por: Johnning, Anna, et al.
Publicado: (2015)

Amino acid substitutions in gyrA and parC associated with quinolone resistance in nalidixic acid-resistant Salmonella isolates
por: Bae, Dong Hwa, et al.
Publicado: (2013)

Characterization of gyrA and parC mutations in ciprofloxacin-resistant Pseudomonas aeruginosa isolates from Tehran hospitals in Iran
por: Farahi, Rosetta Moshirian, et al.
Publicado: (2018)

Life-Threatening Infantile Diarrhea from Fluoroquinolone-Resistant Salmonella enteric Typhimurium with Mutations in Both gyrA and parC
por: Nakaya, Hideo, et al.
Publicado: (2003)

Evaluation of Ciprofloxacin (gyrA, parC Genes) and Tetracycline (tetB Gene) Resistance in Nosocomial Acinetobacter baumannii Infections
por: Nowroozi, Jamileh, et al.
Publicado: (2014)

Identification of the likely translational start of Mycobacterium tuberculosis GyrB
por: Karkare, Shantanu, et al.
Publicado: (2013)

Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam
por: Nguyen, Kinh Van, et al.
Publicado: (2018)

Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs
por: Park, Youjin, et al.
Publicado: (2020)

New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
por: Malik, Seidu, et al.
Publicado: (2012)

Molecular Study of Quinolone Resistance Determining Regions of gyrA Gene and parC Genes in Clinical Isolates of Acintobacter baumannii Resistant to Fluoroquinolone
por: Zaki, Maysaa El Sayed, et al.
Publicado: (2018)

Characterization of non-classical quinolone resistance in Salmonella enterica serovar Typhi: Report of a novel mutation in gyrB gene and diagnostic challenges
por: Gupta, Ruchi, et al.
Publicado: (2015)

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa
por: Feng, Xinyuan, et al.
Publicado: (2019)

Benzohydrazide and Phenylacetamide Scaffolds: New Putative ParE Inhibitors
por: Yele, Vidyasrilekha, et al.
Publicado: (2021)

The First Saudi Report of Novel and Common Mutations in the gyrA and parC Genes Among Pseudomonas Spp. Clinical Isolates Recovered from Taif Area
por: El-Badawy, Mohamed F, et al.
Publicado: (2022)

Multiplex Real-Time Polymerase Chain Reaction-Based Method for the Rapid Detection of gyrA and parC Mutations in Quinolone-Resistant Escherichia coli and Shigella spp.
por: Kim, Junyoung, et al.
Publicado: (2012)

A Novel Mismatched PCR-Restriction Fragment Length Polymorphism Assay for Rapid Detection of gyrA and parC Mutations Associated With Fluoroquinolone Resistance in Acinetobacter baumannii
por: Kakuta, Naoki, et al.
Publicado: (2020)

A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis
por: Singh, Pooja, et al.
Publicado: (2014)

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review
por: Avalos, Elisea, et al.
Publicado: (2015)

The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage
por: Wu, Jinjun, et al.
Publicado: (2011)

Draft Genome Sequence of an Escherichia coli Sequence Type 410 Isolate Harboring bla(NDM-5) Genes with gyrA and parE Mutations, Isolated from Urine Culture in China
por: Huang, Junwei, et al.
Publicado: (2019)

Function inferences from a molecular structural model of bacterial ParE toxin
por: Barbosa, Luiz Carlos Bertucci, et al.
Publicado: (2010)

Expression of different ParE toxins results in conserved phenotypes with distinguishable classes of toxicity
por: Ames, Jessica R., et al.
Publicado: (2019)

Molecular Analysis of Ciprofloxacin Resistance Mechanisms in Malaysian ESBL-Producing Klebsiella pneumoniae Isolates and Development of Mismatch Amplification Mutation Assays (MAMA) for Rapid Detection of gyrA and parC Mutations
por: Al-Marzooq, Farah, et al.
Publicado: (2014)

ParC, a New Partitioning Protein, Is Necessary for the Active Form of ParA From Myxococcus pMF1 Plasmid
por: Sheng, Duohong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_og81j63sosv26ci37ui6391mg8